Araştırma Makalesi
BibTex RIS Kaynak Göster

AKUT MİYOKART ENFARKTÜSÜ GEÇİRMİŞ BİREYLERDE KAÇIRILMIŞ FIRSATLARIN DEĞERLENDİRİLMESİ

Yıl 2025, Cilt: 12 Sayı: 2, 107 - 118, 27.06.2025

Öz

Amaç: Bu çalışmanın amacı, İstanbul’da bir üçüncü basamak eğitim ve araştırma hastanesine başvuran ve son iki yıl içerisinde akut miyokart enfarktüsü (MI) geçirmiş bireylerde, primer ve sekonder korunma düzeyinde kaçırılmış fırsatları belirlemek ve risk farkındalığı ile sağlık hizmetlerine başvuru davranışlarını değerlendirmektir.
Gereç ve Yöntem: Bu kesitsel araştırmada, Ocak 2023-Nisan 2023 tarihleri arasında bir kamu hastanesinin kardiyoloji polikliniğine başvuran ve son iki yıl içinde MI tanısı almış 74 birey ile yüz yüze görüşmeler gerçekleştirilmiştir. Geliştirilen yarı yapılandırılmış anket formu ile sosyodemografik özellikler, kardiyovasküler risk faktörleri, sağlık hizmetlerine erişim ve risk farkındalığına ilişkin veriler toplanmıştır. İstatistiksel analizlerde Mann-Whitney U testi ve Pearson Ki-kare testi kullanılmış, anlamlılık düzeyi p<0,05 olarak kabul edilmiştir.
Bulgular: Katılımcıların %83,8’i erkek olup, median yaş 60,5 yıldır. Sigara kullanımı %60,8, hipertansiyon %62,2, diyabet %43,2 ve hiperlipidemi %67,6 oranında saptanmıştır. İlk MI yaşının medianı 53 yıl olarak bulunmuştur. Risk faktörlerine sahip bireylerin yalnızca %40’ı kalp krizi riski hakkında bilgilendirilmiştir. Katılımcıların %23’ü şikayet olmadan hekime başvurduğunu bildirmiştir. Eğitim düzeyi, cinsiyet, sosyal güvence ve ailede kalp hastalığı öyküsü gibi değişkenlerle doktora başvurma davranışı arasında anlamlı bir ilişki saptanmamıştır.
Sonuç: Çalışmamız, MI geçiren bireylerde değiştirilebilir risk faktörlerinin yaygın olduğunu, ancak risk farkındalığının ve koruyucu sağlık davranışlarının yetersiz kaldığını ortaya koymuştur. Bulgular, birinci basamakta koruyucu hizmetlerin güçlendirilmesi, risk gruplarına yönelik sağlık okuryazarlığı programlarının geliştirilmesi ve toplum temelli müdahalelerin artırılması gerektiğini göstermektedir. Ayrıca sosyal tıp perspektifiyle, sağlık hizmetlerine erişimdeki eşitsizliklerin giderilmesi ve bütüncül sağlık politikalarının benimsenmesi önem taşımaktadır.

Kaynakça

  • Roffi M, Patrono C, Collet J-P, Mueller C, Valgimigli M, Andreotti F, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal 2016; 37 (3): 267-315.
  • Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal 2018; 39 (2): 119-177.
  • Özkan AA. Akut Koroner Sendromlar: Epidemiyoloji. Türk Kardiyoloji Derneği Arşivi 2013; 41 (1): 1-3.
  • Onat A, Yüksel M, Köroğlu B, Gümrükçüoğlu HA, Aydın M, Çakmak HA ve ark. TEKHARF 2012: Genel ve koroner mortalite ile metabolik sendrom prevalansı eğilimleri. Türk Kardiyoloji Derneği Arşivi 2013; 41 (5): 373-378.
  • Mackay J, Mensah GA, Mendis S, Greenland K. The atlas of heart disease and stroke. World Health Organization, 2004. Erişim: (https://iris.who.int/handle/10665/43007). Erişim Tarihi: 28.04.2025.
  • Yusuf S, Hawken S, Ôunpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. The Lancet 2004; 364 (9438): 937-952.
  • WHO global report on trends in prevalence of tobacco use 2000–2030. World Health Organization, 2024. Erişim: (https://www.who.int/publications/i/item/9789240088283). Erişim Tarihi: 28.04.2025.
  • Türkiye Sağlık Araştırması 2022. Türkiye İstatistik Kurumu, 2023. Erişim: (https://data.tuik.gov.tr/Bulten/Index?p=Turkiye-Saglik-Arastirmasi-2022-49747). Erişim Tarihi: 28.04.2025.
  • Marmot M, Allen J, Bell R, Bloomer E, Goldblatt P. WHO European review of social determinants of health and the health divide. The Lancet 2012; 380 (9846): 1011-1029.
  • Sequist TD, Marshall R, Lampert S, Buechler EJ, Lee TH. Missed opportunities in the primary care management of early acute ischemic heart disease. Archives of Internal Medicine 2006; 166 (20): 2237-2243.
  • Irmak Z, Fesci H. Akut Miyokard İnfarktüsünde Sekonder Koruma. Hacettepe Üniversitesi Hemşirelik Fakültesi Dergisi 2005; 12 (1): 84-96.
  • Dracup K, Moser DK, Eisenberg M, Meischke H, Alonzo AA, Braslow A. Causes of delay in seeking treatment for heart attack symptoms. Social Science & Medicine 1995; 40 (3): 379-392.
  • Smith Jr SC. Clinical treatment of dyslipidemia: practice patterns and missed opportunities. The American Journal of Cardiology 2000; 86 (12): 62-65.
  • Nutbeam D. Health literacy as a public health goal: a challenge for contemporary health education and communication strategies into the 21st century. Health Promotion International 2000; 15 (3): 259-267.
  • Marmot M. Social determinants of health inequalities. The Lancet 2005; 365 (9464): 1099-1104.
  • Childress JF, Beauchamp TL. Principles of biomedical ethics. Oxford University Press, 1994.
  • Dugani SB, Melendez APA, Reka R, Hydoub YM, McCafferty SN, Murad MH, et al. Risk factors associated with premature myocardial infarction: a systematic review protocol. BMJ open 2019; 9 (2): e023647.
  • Aladağ N, Özdemir M, Yurtdaş M, Gümrükçüoğlu HA. Akut Koroner Sendrom ile Başvuran Hastaların Klinik Özellikleri, Risk Faktörleri ve Tedavi Yöntemleri. Van Tıp Dergisi 2019; 26 (4): 505-513.
  • Canu M, Khouri C, Marliere S, Vautrin E, Piliero N, Ormezzano O, et al. Prognostic significance of severe coronary microvascular dysfunction post-PCI in patients with STEMI: A systematic review and meta-analysis. PLoS One 2022; 17 (5): e0268330.
  • Mensah GA, Fuster V, Murray CJ, Roth GA, Diseases GBoC, Collaborators R. Global burden of cardiovascular diseases and risks, 1990-2022. Journal of the American College of Cardiology 2023; 82 (25): 2350-2473.
  • Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: A report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Journal of the American College of Cardiology 2019; 140 (11): e-597-e-624.
  • Topuzoğlu A, Hıdıroğlu S, Önsüz M, Polat G. Missed opportunities for chronic diseases prevention in a primary health care center in İstanbul. TAF Preventive Medicine Bulletin 2011; 10 (6): 665-674.
  • Marx N, Federici M, Schütt K, Müller-Wieland D, Ajjan RA, Antunes MJ, et al. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC). European Heart Journal 2023; 44 (39): 4043-4140.
  • Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. The Lancet 2004; 364 (9438): 937-952.
  • Murray CJ. Findings from the Global Burden of Disease Study 2021. The Lancet 2024; 403 (10440): 2259-2262.
  • Naghavi M, Ong KL, Aali A, Ababneh HS, Abate YH, Abbafati C, et al. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: A systematic analysis for the Global Burden of Disease Study 2021. The Lancet 2024; 403 (10440): 2100-2132.
  • Magnani JW, Mujahid MS, Aronow HD, Cené CW, Dickson VV, Havranek E, et al. Health literacy and cardiovascular disease: fundamental relevance to primary and secondary prevention: A scientific statement from the American Heart Association. Circulation 2018; 138 (2): e48-e74.
  • Global action plan for the prevention and control of noncommunicable diseases 2013-2020. World Hearth Organization, 2013. Erişim: (https://www.who.int/publications/i/item/9789241506236). Erişim Tarihi: 28.04.2025.
  • Preventing heart disease. Centers for Disease Control and Prevention, 2024. Erişim: (https://www.cdc.gov/heart-disease/prevention/index.html). Erişim Tarihi: 28.04.2025.
  • Shahmohamadi E, Ayati A, Sharifi Y, Ebrahimi P, Gooshki ES, Djalalinia S, et al. Ethical considerations in prevention and management of non-communicable diseases: A narrative review. Journal of Medical Ethics and History of Medicine 2024; 17: 19.
  • Finn JC, Bett JHN, Shilton TR, Cunningham C, Thompson PL. Patient delay in responding to symptoms of possible heart attack: can we reduce time to care? Medical Journal of Australia 2007; 187 (5): 293-298.
  • Navarro V. What we mean by social determinants of health. Global Health Promotion 2009; 16 (1): 5-16.
  • Whitehead M, Dahlgren G. Concepts and Principles for tackling social inequities in health: Levelling up Part 1. Copenhagen: World Health Organization, 2006. Erişim: (https://www.enothe.eu/cop/docs/concepts_and_principles.pdf). Erişim Tarihi: 28.04.2025.
  • Türkiye Kalp ve Damar Hastalıkları Önleme ve Kontrol Programı 2021-2026. Ankara: TC Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü, 2021: 104. Erişim: (https://hsgm.saglik.gov.tr/depo/birimler/kronik-hastaliklar-ve-yasli-sagligi-db/Dokumanlar/Kitaplar/KalpDamarEylemPlani_2021-2026.pdf). Erişim Tarihi: 28.04.2025.
  • Sağlık İstatistikleri Yıllığı 2022. Ankara: TC Sağlık Bakanlığı, 2024. Erişim: (https://dosyasb.saglik.gov.tr/Eklenti/48054/0/siy202205042024pdf.pdf). Erişim Tarihi: 28.04.2025.
  • Beasant B, Lee G, Vaughan V, Lotfaliany M, Hosking S. Health literacy and cardiovascular disease prevention: A systematic scoping review protocol. BMJ open 2022; 12 (6): e054977.
  • Beauchamp T, Childress J. Principles of Biomedical Ethics: Marking Its Fortieth Anniversary. Am J Bioeth 2019; 19 (11): 9-12.
  • Marmot M, Allen JJ. Social determinants of health equity. Am J Public Health 2014; 104 (Suppl 4): S517–S519
  • Health literacy development for the prevention and control of noncommunicable diseases: Volume 2. A globally relevant perspective. World Health Organization, 2022. Erişim: (https://www.who.int/publications/i/item/9789240055353). Erişim Tarihi: 28.04.2025.
  • Ethics and governance of artificial intelligence for health: WHO Guidance. World Health Organization, 2021. Erişim: (https://www.who.int/publications/i/item/9789240029200). Erişim Tarihi: 28.04.2025.

Evaluation of Missed Opportunities in Individuals with Acute Myocardial Infarction

Yıl 2025, Cilt: 12 Sayı: 2, 107 - 118, 27.06.2025

Öz

Objective: This study aimed to identify missed opportunities at the levels of primary and secondary prevention and to evaluate risk awareness and healthcare-seeking behaviors among individuals who experienced acute myocardial infarction (MI) within the past two years at a tertiary education and research hospital in Istanbul.
Materials and Methods: In this cross-sectional study, face-to-face interviews were conducted with 74 individuals who were diagnosed with MI and admitted to the cardiology outpatient clinic between January 2023 and April 2023. Data were collected using a semi-structured questionnaire developed based on the literature, covering sociodemographic characteristics, cardiovascular risk factors, access to healthcare, and indicators of risk awareness. The Mann-Whitney U test and Pearson’s Chi-square test were used for statistical analysis, with a significance level set at p<0.05.
Results: Among the participants, 83.8% were male, and the median age was 60.5 years. The rates of smoking, hypertension, diabetes, and hyperlipidemia were found to be 60.8%, 62.2%, 43.2%, and 67.6%, respectively. The median age at first MI was 53 years. Only about 40% of participants with risk factors had been informed about their risk of heart attack. While 23% of participants reported visiting a physician without symptoms to assess cardiovascular risk, no statistically significant association was found between healthcare-seeking behavior and variables such as education level, gender, presence of social security, or family history of heart disease.
Conclusion: This study revealed that modifiable risk factors are highly prevalent among individuals who experienced MI, yet risk awareness and preventive health behaviors remain inadequate. The findings highlight the necessity of strengthening preventive services at the primary care level, developing targeted health literacy programs, and promoting community-based interventions. From a social medicine perspective, addressing inequalities in healthcare access and adopting comprehensive health policies are crucial for effective prevention.

Kaynakça

  • Roffi M, Patrono C, Collet J-P, Mueller C, Valgimigli M, Andreotti F, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal 2016; 37 (3): 267-315.
  • Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal 2018; 39 (2): 119-177.
  • Özkan AA. Akut Koroner Sendromlar: Epidemiyoloji. Türk Kardiyoloji Derneği Arşivi 2013; 41 (1): 1-3.
  • Onat A, Yüksel M, Köroğlu B, Gümrükçüoğlu HA, Aydın M, Çakmak HA ve ark. TEKHARF 2012: Genel ve koroner mortalite ile metabolik sendrom prevalansı eğilimleri. Türk Kardiyoloji Derneği Arşivi 2013; 41 (5): 373-378.
  • Mackay J, Mensah GA, Mendis S, Greenland K. The atlas of heart disease and stroke. World Health Organization, 2004. Erişim: (https://iris.who.int/handle/10665/43007). Erişim Tarihi: 28.04.2025.
  • Yusuf S, Hawken S, Ôunpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. The Lancet 2004; 364 (9438): 937-952.
  • WHO global report on trends in prevalence of tobacco use 2000–2030. World Health Organization, 2024. Erişim: (https://www.who.int/publications/i/item/9789240088283). Erişim Tarihi: 28.04.2025.
  • Türkiye Sağlık Araştırması 2022. Türkiye İstatistik Kurumu, 2023. Erişim: (https://data.tuik.gov.tr/Bulten/Index?p=Turkiye-Saglik-Arastirmasi-2022-49747). Erişim Tarihi: 28.04.2025.
  • Marmot M, Allen J, Bell R, Bloomer E, Goldblatt P. WHO European review of social determinants of health and the health divide. The Lancet 2012; 380 (9846): 1011-1029.
  • Sequist TD, Marshall R, Lampert S, Buechler EJ, Lee TH. Missed opportunities in the primary care management of early acute ischemic heart disease. Archives of Internal Medicine 2006; 166 (20): 2237-2243.
  • Irmak Z, Fesci H. Akut Miyokard İnfarktüsünde Sekonder Koruma. Hacettepe Üniversitesi Hemşirelik Fakültesi Dergisi 2005; 12 (1): 84-96.
  • Dracup K, Moser DK, Eisenberg M, Meischke H, Alonzo AA, Braslow A. Causes of delay in seeking treatment for heart attack symptoms. Social Science & Medicine 1995; 40 (3): 379-392.
  • Smith Jr SC. Clinical treatment of dyslipidemia: practice patterns and missed opportunities. The American Journal of Cardiology 2000; 86 (12): 62-65.
  • Nutbeam D. Health literacy as a public health goal: a challenge for contemporary health education and communication strategies into the 21st century. Health Promotion International 2000; 15 (3): 259-267.
  • Marmot M. Social determinants of health inequalities. The Lancet 2005; 365 (9464): 1099-1104.
  • Childress JF, Beauchamp TL. Principles of biomedical ethics. Oxford University Press, 1994.
  • Dugani SB, Melendez APA, Reka R, Hydoub YM, McCafferty SN, Murad MH, et al. Risk factors associated with premature myocardial infarction: a systematic review protocol. BMJ open 2019; 9 (2): e023647.
  • Aladağ N, Özdemir M, Yurtdaş M, Gümrükçüoğlu HA. Akut Koroner Sendrom ile Başvuran Hastaların Klinik Özellikleri, Risk Faktörleri ve Tedavi Yöntemleri. Van Tıp Dergisi 2019; 26 (4): 505-513.
  • Canu M, Khouri C, Marliere S, Vautrin E, Piliero N, Ormezzano O, et al. Prognostic significance of severe coronary microvascular dysfunction post-PCI in patients with STEMI: A systematic review and meta-analysis. PLoS One 2022; 17 (5): e0268330.
  • Mensah GA, Fuster V, Murray CJ, Roth GA, Diseases GBoC, Collaborators R. Global burden of cardiovascular diseases and risks, 1990-2022. Journal of the American College of Cardiology 2023; 82 (25): 2350-2473.
  • Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: A report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Journal of the American College of Cardiology 2019; 140 (11): e-597-e-624.
  • Topuzoğlu A, Hıdıroğlu S, Önsüz M, Polat G. Missed opportunities for chronic diseases prevention in a primary health care center in İstanbul. TAF Preventive Medicine Bulletin 2011; 10 (6): 665-674.
  • Marx N, Federici M, Schütt K, Müller-Wieland D, Ajjan RA, Antunes MJ, et al. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC). European Heart Journal 2023; 44 (39): 4043-4140.
  • Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. The Lancet 2004; 364 (9438): 937-952.
  • Murray CJ. Findings from the Global Burden of Disease Study 2021. The Lancet 2024; 403 (10440): 2259-2262.
  • Naghavi M, Ong KL, Aali A, Ababneh HS, Abate YH, Abbafati C, et al. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: A systematic analysis for the Global Burden of Disease Study 2021. The Lancet 2024; 403 (10440): 2100-2132.
  • Magnani JW, Mujahid MS, Aronow HD, Cené CW, Dickson VV, Havranek E, et al. Health literacy and cardiovascular disease: fundamental relevance to primary and secondary prevention: A scientific statement from the American Heart Association. Circulation 2018; 138 (2): e48-e74.
  • Global action plan for the prevention and control of noncommunicable diseases 2013-2020. World Hearth Organization, 2013. Erişim: (https://www.who.int/publications/i/item/9789241506236). Erişim Tarihi: 28.04.2025.
  • Preventing heart disease. Centers for Disease Control and Prevention, 2024. Erişim: (https://www.cdc.gov/heart-disease/prevention/index.html). Erişim Tarihi: 28.04.2025.
  • Shahmohamadi E, Ayati A, Sharifi Y, Ebrahimi P, Gooshki ES, Djalalinia S, et al. Ethical considerations in prevention and management of non-communicable diseases: A narrative review. Journal of Medical Ethics and History of Medicine 2024; 17: 19.
  • Finn JC, Bett JHN, Shilton TR, Cunningham C, Thompson PL. Patient delay in responding to symptoms of possible heart attack: can we reduce time to care? Medical Journal of Australia 2007; 187 (5): 293-298.
  • Navarro V. What we mean by social determinants of health. Global Health Promotion 2009; 16 (1): 5-16.
  • Whitehead M, Dahlgren G. Concepts and Principles for tackling social inequities in health: Levelling up Part 1. Copenhagen: World Health Organization, 2006. Erişim: (https://www.enothe.eu/cop/docs/concepts_and_principles.pdf). Erişim Tarihi: 28.04.2025.
  • Türkiye Kalp ve Damar Hastalıkları Önleme ve Kontrol Programı 2021-2026. Ankara: TC Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü, 2021: 104. Erişim: (https://hsgm.saglik.gov.tr/depo/birimler/kronik-hastaliklar-ve-yasli-sagligi-db/Dokumanlar/Kitaplar/KalpDamarEylemPlani_2021-2026.pdf). Erişim Tarihi: 28.04.2025.
  • Sağlık İstatistikleri Yıllığı 2022. Ankara: TC Sağlık Bakanlığı, 2024. Erişim: (https://dosyasb.saglik.gov.tr/Eklenti/48054/0/siy202205042024pdf.pdf). Erişim Tarihi: 28.04.2025.
  • Beasant B, Lee G, Vaughan V, Lotfaliany M, Hosking S. Health literacy and cardiovascular disease prevention: A systematic scoping review protocol. BMJ open 2022; 12 (6): e054977.
  • Beauchamp T, Childress J. Principles of Biomedical Ethics: Marking Its Fortieth Anniversary. Am J Bioeth 2019; 19 (11): 9-12.
  • Marmot M, Allen JJ. Social determinants of health equity. Am J Public Health 2014; 104 (Suppl 4): S517–S519
  • Health literacy development for the prevention and control of noncommunicable diseases: Volume 2. A globally relevant perspective. World Health Organization, 2022. Erişim: (https://www.who.int/publications/i/item/9789240055353). Erişim Tarihi: 28.04.2025.
  • Ethics and governance of artificial intelligence for health: WHO Guidance. World Health Organization, 2021. Erişim: (https://www.who.int/publications/i/item/9789240029200). Erişim Tarihi: 28.04.2025.
Toplam 40 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Konular Sağlık Hizmetleri ve Sistemleri (Diğer)
Bölüm ARAŞTIRMA MAKALESİ
Yazarlar

Önder Demiröz 0000-0002-2401-6109

Miray Sancaktar Demiröz 0000-0001-6113-3163

Oytun Sevil 0009-0000-0991-4878

Sakine Beyza Üstün 0009-0006-0958-1413

Kürşat Uyğul 0009-0004-3210-2092

Rümeysa Kılıç 0009-0002-8256-707X

Zeynep Tuye Çakır 0009-0002-7940-8836

Seyhan Hıdıroğlu 0000-0001-8656-4613

Yayımlanma Tarihi 27 Haziran 2025
Gönderilme Tarihi 29 Nisan 2025
Kabul Tarihi 15 Haziran 2025
Yayımlandığı Sayı Yıl 2025 Cilt: 12 Sayı: 2

Kaynak Göster

Vancouver Demiröz Ö, Sancaktar Demiröz M, Sevil O, Üstün SB, Uyğul K, Kılıç R, vd. AKUT MİYOKART ENFARKTÜSÜ GEÇİRMİŞ BİREYLERDE KAÇIRILMIŞ FIRSATLARIN DEĞERLENDİRİLMESİ. TJOB. 2025;12(2):107-18.